Business Wire

NY-WEA-GRP-POLICIES

Share
Women’s Entrepreneurship Accelerator Publication Establishes the Business Case for Gender-Responsive Procurement

The Women’s Entrepreneurship Accelerator (WEA) today announced the publication of an Advocacy Brief titled “Procurement’s strategic value: Why gender-responsive procurement makes business sense” which presents compelling evidence of the benefits for strengthening the participation of women in private sector supply chains in realizing inclusive economic growth and sustainable development.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220505005120/en/

Developed by UN Women and funded by Mary Kay Inc. in support of WEA, the Advocacy Brief highlights the rollback on progress in achieving gender equality as a result of the COVID-19 pandemic, as well as how increasing levels of economic insecurity, supply chain interruptions and unprecedented climate and environmental shocks have a disproportionate impact on women given their unequal position in society.

The publication echoes previous studies that show that economies have better opportunities to grow and are more resilient to crises if women and men have equal rights.1 However, huge challenges remain. Women entrepreneurs continue to face many obstacles including lack of access to capital on both domestic and international markets; fewer entrepreneurship networks compared with men; and policies that discourage female labor market participation.2 Globally, while one in three businesses are owned by women, 3 women only win an estimated one percent of the global spend of large corporations .4 Unequal gender laws also hinder women’s economic opportunity. For instance, nearly 2.4 billion women of working age still do not enjoy the same economic rights as men.5 Despite these statistics, women entrepreneurs remain a solution for many challenges the world faces today and the evidence shows there is a direct correlation between an increase in women entrepreneurship and economic growth, sustainable development, and more inclusive and resilient societies.6

The data presented in the Advocacy Brief outline how the adoption of gender-responsive (GRP) policies and practices through procurement processes is a strategic lever to mitigate the impact of the structural barriers women face and at the same time improve businesses and strengthen economies. The Advocacy Brief cautions that failing to adopt GRP is a wasted opportunity. The evidence is clear. Reducing gender inequalities is good for business and is smart economics.

“Gender-responsive procurement affects corporate profitability, risk mitigation, innovation, and sustainability. When women entrepreneurs are excluded from the procurement pipeline, companies risk leaving a considerable amount of talent, creativity, and expertise on the table. GRP is a winning business strategy as well as a powerful catalyst for change,” said Deborah Gibbins, Chief Operating Officer, Mary Kay, Inc., and inceptor of WEA.

To inform the Advocacy Brief, UN Women engaged over 350 stakeholders in 2021, of which over 150 private sector companies were represented, and incorporated 7 case studies on companies’ procurement journeys to create an evidence base for why businesses should adopt gender-responsive procurement. Stakeholder engagement took the form of interviews, a survey and a community of practice, which benefitted from dissemination across a wide range of networks, including the membership and networks of UN Global Compact’s (UNGC).

Companies reported that GRP leads to:

  • Increased revenue and reduced procurement spend,
  • Greater supplier availability and resilience,
  • Strengthened brand reputation,
  • More innovation and adaptability,
  • Improved service delivery due to greater agility, and
  • Strengthened markets through local economic development and inclusive growth.

As the Advocacy Brief notes “inclusive and sustainable development is paramount for businesses seeking to both stabilize themselves in a volatile economy and benefit from its future growth. Widening gender inequalities hurt all companies, including women entrepreneurs vital to robust and resilient supply chains and the businesses that rely on them.”

Reflecting the increased focus on environmental, social and governance (ESG) issues by companies, the Advocacy Brief notes how “the implementation of GRP allows companies to practice and institutionalize ESG values and importantly contribute to women’s empowerment and the Sustainable Development Goals (SDGs). Through the adoption of GRP principles, businesses can make progress towards multiple goals, including gender equality (SDG 5) and reduced inequalities (SDG 10) in addition to responsible consumption and production (SDG 12), eliminating poverty (SDG 1) and decent work and economic growth (SDG 8).”

“Achieving the Sustainable Development Goals is not something that can be done by women alone, or by business alone, or by government alone. The only way for us to be able to really make progress is if all – business included – work together towards a common purpose,” said Anita Bhatia , Assistant Secretary-General and Deputy Executive Director of UN Women.

Through the release of this report WEA calls on the private sector to adopt GRP strategies and integrate women into global value chains as a vehicle to advance the SDGs. This makes business sense while at the same time advances women’s economic empowerment which benefits economies and societies at large.

The Advocacy Brief is available here .

About the Women’s Entrepreneurship Accelerator

The Women’s Entrepreneurship Accelerator (WEA) is a multi-stakeholder partnership on women’s entrepreneurship established during UNGA 74. It convenes six UN agencies, International Labour Organization (ILO), International Trade Centre (ITC), International Telecommunication Union (ITU), UN Development Programme (UNDP), UN Global Compact (UNGC), UN Women and Mary Kay Inc. to empower 5 million women entrepreneurs by 2030.

The ultimate goal of the initiative is to maximize the development impact of women entrepreneurship in achieving the Sustainable Development Goals (SDGs) by creating an enabling ecosystem for women entrepreneurs around the world. The Accelerator exemplifies the transformational power of a multi-partnership of unique magnitude to harness the potential of women entrepreneurs. Learn more at we-accelerate. Follow us: Twitter (We_Accelerator), Instagram (@we_accelerator), Facebook (@womensentrepreneurshipaccelerator), LinkedIn (@womensentrepreneurshipaccelerator)


1 World Development Report. 2012: Gender Equality and Development: https://openknowledge.worldbank.org/handle/10986/4391 .

2 European Commission and OECD Policy Brief on Women’s Entrepreneurship. 2017: https://www.oecd.org/cfe/smes/Policy-Brief-on-Women-s-Entrepreneurship.pdf

3 World Bank. 2020. Enterprise Surveys, World Bank Gender Data Portal: https://www.worldbank.org/en/data/datatopics/gender

4 Vazquez, E.A. and A.J. Sherman. 2013. Buying for Impact: How to Buy from Women and Change the World. Charleston, USA: Advantage

5 World Bank Group. 2022.. Women, Business and the Law 2022. Washington, DC: World Bank

6 UN Women Facts and Figures: Economic Empowerment: https://www.unwomen.org/en/what-we-do/economic-empowerment/facts-and-figures

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release

At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,

Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release

Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP

Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release

Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through

Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse

Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release

Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye